Nissan Chemical 관리

관리 기준 확인 3/4

Nissan Chemical CEO는 Shinsuke Yagi, Apr2021 에 임명되었습니다 의 임기는 3.58 년입니다. 총 연간 보상은 ¥ 96.00M, 68.8% 로 구성됩니다. 68.8% 급여 및 31.3% 보너스(회사 주식 및 옵션 포함). 는 € 395.20K 가치에 해당하는 회사 주식의 0.009% 직접 소유합니다. 395.20K. 경영진과 이사회의 평균 재임 기간은 각각 3.6 년과 3.9 년입니다.

주요 정보

Shinsuke Yagi

최고 경영자

JP¥96.0m

총 보상

CEO 급여 비율	68.8%
CEO 임기	3.6yrs
CEO 소유권	0.009%
경영진 평균 재임 기간	3.6yrs
이사회 평균 재임 기간	3.9yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Shinsuke Yagi 의 보수는 Nissan Chemical 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	JP¥39b
Jun 30 2024	n/a	n/a	JP¥37b
Mar 31 2024	JP¥96m	JP¥66m	JP¥38b

보상 대 시장: Shinsuke 의 총 보상 ($USD 620.64K ) German 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 3.52M ).

보상과 수익: Shinsuke 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Shinsuke Yagi (62 yo)

3.6yrs

테뉴어

JP¥96,000,000

보상

Mr. Shinsuke Yagi serves as Chief Operating Officer and President at Nissan Chemical Corp. since 2021 and served as its Senior Managing Executive Officer since April 1, 2020 until 2021 also served as its H...

리더십 팀

이름	위치	테뉴어	보상	소유권
Shinsuke Yagi	President	3.6yrs	JP¥96.00m	0.0087% € 395.2k
Hideki Daimon	Director	less than a year	데이터 없음	0.0014% € 65.7k
Hideyuki Endo	Managing Executive Officer	1.8yrs	데이터 없음	데이터 없음
Yuji Nishida	Executive Officer & Plant Manager of Toyama Plant	no data	데이터 없음	데이터 없음
Takashi Honda	Senior EVP & Director	7.8yrs	데이터 없음	0.0058% € 263.8k
Motoaki Ishikawa	Senior Managing Executive Officer	no data	데이터 없음	0.0051% € 230.7k
Satoshi Kageshima	Executive Officer & Head of Intellectual Property Dept.	1.8yrs	데이터 없음	데이터 없음
Takeshi Matsuoka	Managing Executive Officer	5.6yrs	데이터 없음	0.0029% € 131.9k
Yuji Sato	Senior Managing Executive Officer & Head of Agricultural Chemicals Division	4.6yrs	데이터 없음	데이터 없음
Wataru Kawashima	Executive Officer	3.8yrs	데이터 없음	데이터 없음
Toshiaki Okikawa	Executive Officer & Head of Chemicals Division	no data	데이터 없음	데이터 없음
Toshiyuki Hata	Managing Executive Officer and Head of Production Technology Dept. & Production Technology	1.8yrs	데이터 없음	데이터 없음

3.6yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 관리: NSC 의 관리팀은 경험 ( 3.6 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Shinsuke Yagi	President	4.4yrs	JP¥96.00m	0.0087% € 395.2k
Hideki Daimon	Director	2.4yrs	데이터 없음	0.0014% € 65.7k
Takashi Honda	Senior EVP & Director	7.4yrs	데이터 없음	0.0058% € 263.8k
Motoaki Ishikawa	Senior Managing Executive Officer	2.4yrs	데이터 없음	0.0051% € 230.7k
Takeshi Matsuoka	Managing Executive Officer	2.4yrs	데이터 없음	0.0029% € 131.9k
Kojiro Kinoshita	Chairman of the Board	22.4yrs	JP¥96.00m	0.072% € 3.3m
Hidehito Obayashi	Independent Outside Director	5.4yrs	데이터 없음	데이터 없음
Noriyuki Katayama	Outside Audit & Supervisory Board Member	10.4yrs	데이터 없음	0.00073% € 33.1k
Kazunori Kataoka	Independent Outside Director	4.4yrs	데이터 없음	데이터 없음
Kazuhiko Ohrai	Auditor	2.4yrs	데이터 없음	0.0095% € 428.3k
Nakagawa Miyuki	Independent Outside Director	3.4yrs	데이터 없음	데이터 없음
Takeoka Yuko	Independent Outside Director	1.4yrs	데이터 없음	데이터 없음

3.9yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: NSC 의 이사회는 경험(평균 재직 기간 3.9 년)으로 간주됩니다.

Nissan Chemical 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Second quarter 2025 earnings released: EPS: JP¥64.95 (vs JP¥52.08 in 2Q 2024)

Nissan Chemical Corporation to Report Q3, 2025 Results on Feb 07, 2025

Upcoming dividend of JP¥70.00 per share

First quarter 2025 earnings released: EPS: JP¥83.77 (vs JP¥87.39 in 1Q 2024)

Nissan Chemical Corporation to Report Q2, 2025 Results on Nov 11, 2024

Final dividend of JP¥70.00 announced

Investor sentiment deteriorates as stock falls 15%

Full year 2024 earnings released: EPS: JP¥273 (vs JP¥291 in FY 2023)

Nissan Chemical Corporation to Report Q1, 2025 Results on Aug 09, 2024

Less than half of directors are independent

Nissan Chemical Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024

Second quarter 2024 earnings released: EPS: JP¥52.08 (vs JP¥69.58 in 2Q 2023)

Nissan Chemical Corporation to Report Q3, 2024 Results on Feb 09, 2024

Upcoming dividend of JP¥70.00 per share at 2.5% yield

First quarter 2024 earnings released: EPS: JP¥87.39 (vs JP¥98.13 in 1Q 2023)

Nissan Chemical Corporation to Report Q2, 2024 Results on Nov 10, 2023

Full year 2023 earnings released: EPS: JP¥291 (vs JP¥272 in FY 2022)

Nissan Chemical Corporation Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending March 31, 2024

Nissan Chemical Corporation (TSE:4021) announces an Equity Buyback for 1,250,000 shares, representing 0.89% for ¥5,000 million.

Nissan Chemical Corporation to Report Q1, 2024 Results on Aug 10, 2023

Upcoming dividend of JP¥94.00 per share at 2.8% yield

Third quarter 2023 earnings released: EPS: JP¥50.21 (vs JP¥65.66 in 3Q 2022)

Nissan Chemical Corporation to Report Fiscal Year 2023 Results on May 15, 2023

Nissan Chemical Corporation Provides Dividend Guidance for the Year Ending March 31, 2023

Second quarter 2023 earnings released: EPS: JP¥69.58 (vs JP¥52.18 in 2Q 2022)

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥69.58 (vs JP¥52.18 in 2Q 2022)

Nissan Chemical Corporation to Report Q3, 2023 Results on Feb 10, 2023

Nissan Chemical Corporation to Report Q2, 2023 Results on Nov 11, 2022

Upcoming dividend of JP¥70.00 per share

First quarter 2023 earnings released: EPS: JP¥98.13 (vs JP¥61.73 in 1Q 2022)

Nissan Chemical Corporation Revises Dividend Guidance for the Second Quarter Ending September 30, 2022 and Year Ending March 31, 2023

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: JP¥272 (vs JP¥232 in FY 2021)

Nissan Chemical Corporation Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2023

Nissan Chemical Corporation to Report Q1, 2023 Results on Aug 08, 2022

Less than half of directors are independent

Upcoming dividend of JP¥68.00 per share

Tokyo District Court Renders Judgment on the Patent Infringement Lawsuit Concerning Edirol Capsules Against Sawai Pharmaceutical Co., Ltd., Nichi- Iko Pharmaceutical Co., Ltd. and Nissan Chemical Corporation

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Nissan Chemical Corporation to Report Q4, 2022 Results on May 13, 2022

Second quarter 2022 earnings released: EPS JP¥52.18 (vs JP¥43.55 in 2Q 2021)

Upcoming dividend of JP¥48.00 per share

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS JP¥61.73 (vs JP¥52.37 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥232 (vs JP¥210 in FY 2020)

Nissan Chemical Corporation Announces Dividend for the Full Year Ended March 31, 2021, Payable on June 28, 2021; Provides Divided Guidance for the Second Quarter Ending March 31, 2022 and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2022

Upcoming dividend of JP¥52.00 per share

New 90-day low: €44.00

Chugai Pharmaceutical Co., Ltd. Refiles Patent Infringement Lawsuit Concerning Edirol Capsules

Third quarter 2021 earnings released: EPS JP¥30.92 (vs JP¥20.64 in 3Q 2020)

Revenue misses expectations

Nissan Chemical Corporation to Report Fiscal Year 2021 Results on May 14, 2021

Chugai Pharmaceutical Co., Ltd. Files Patent Infringement Lawsuit Against Nissan Chemical Corporation, Sawai Pharmaceutical Co., Ltd. and Nichi-Iko Pharmaceutical Co., Ltd

Second quarter 2021 earnings released: EPS JP¥43.55

Revenue misses expectations

Nissan Chemical Corporation to Report Q3, 2021 Results on Feb 05, 2021

New 90-day high: €46.00

Nissan Chemical Corporation to Report Q2, 2021 Results on Nov 12, 2020

First quarter earnings released

Earnings released

New 90-day high - €48.00

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령